| Literature DB >> 29871697 |
A Mitropoulos1, A Gumber2, H Crank1, M Akil3, M Klonizakis4.
Abstract
BACKGROUND: Aerobic exercise in general and high-intensity interval training (HIIT) specifically is known to improve vascular function in a range of clinical conditions. HIIT in particular has demonstrated improvements in clinical outcomes, in conditions that have a strong macroangiopathic component. Nevertheless, the effect of HIIT on microcirculation in systemic sclerosis (SSc) patients is yet to be investigated. Therefore, the purpose of the study was to compare the effects of two HIIT protocols (cycle and arm cranking) on the microcirculation of the digital area in SSc patients.Entities:
Keywords: High-intensity interval training; Quality of life; Vascular function
Mesh:
Year: 2018 PMID: 29871697 PMCID: PMC5989435 DOI: 10.1186/s13075-018-1605-0
Source DB: PubMed Journal: Arthritis Res Ther ISSN: 1478-6354 Impact factor: 5.156
Fig. 1CONSORT flow diagram. ACE arm crank ergometer, CE cycle ergometer
Demographic data (means ± SD)
| Baseline ACE | Baseline CE | Baseline Control | |
|---|---|---|---|
| Age (years) | 69.1 ± 9.7 | 65.1 ± 10 | 62.2 ± 14.3 |
| Body weight (kg) | 69 ± 15.8 | 66 ± 9.7 | 73.2 ± 14.8 |
| Body mass index (kg/m2) | 25.6 ± 4.8 | 24.5 ± 3.6 | 27.3 ± 4.0 |
| Stature (cm) | 163.7 ± 9.1 | 164.4 ± 7.9 | 163.4 ± 6.7 |
| Disease duration (yrs) | 7.8 ± 2.3 | 7.7 ± 2.1 | 6.3 ± 2.0 |
| Digital ulcers (treatment iloprost infusion) | 0/10 | 0/10 | 4/11 |
| Raynaud’s treatment | 6/10 | 5/10 | 8/10 |
| Nifedipine | 4/10 | 4/10 | 4/10 |
| Sildenafil | 2/10 | 1/10 | 4/10 |
| Blood pressure treatment | 6/10 | 4/10 | 4/10 |
| Candesartan | 4/10 | 0/10 | 1/10 |
| Ramipril | 2/10 | 4/10 | 3/10 |
ACE arm crank ergometer, CE cycle ergometer
Fig. 2Schematic training protocol
Definitions of TcpO2 quantities
| TcpO2 quantity | Definition |
|---|---|
| Baseline | The arithmetic mean of maximum TcpO2 at rest. |
| TcpO2max | The highest TcpO2 value recorded every minute of exercise or at rest. |
| Maximum change from baseline (ΔTcpO2max) | The outcome of the subtraction of baseline from TcpO2max: e.g. TcpO2max - baseline |
| Changes in transcutaneous oxygen pressure (ΔTcpO2) | The average sum of the change from baseline at rest and exercise period: e.g. (Σ)ΔY1…n) / n) = ΔTcpO2 |
ΔTcpO transcutaneous oxygen tension
Physiological and quality of life outcomes
| ACE ( | CE ( | Control ( | ||||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | |
| ACh CVC | 0.14 ± 0.06 | 0.19 ± 0.08 | 0.20 ± 0.11 | 0.26 ± 0.1 | 0.20 ± 0.08 | 0.15 ± 0.08 |
| ACh CVCmax | 1.28 ± 0.78 | 1.56 ± 0.88* | 1.49 ± 0.99 | 1.26 ± 0.52 | 1.40 ± 0.78 | 0.82 ± 0.47 |
| ACh Tmax (sec) | 159.4 ± 83 | 104.1 ± 71.8 | 172 ± 57.9 | 119.4 ± 82.9 | 127.9 ± 51.1 | 149.9 ± 70.3 |
| SNP CVC | 0.15 ± 0.08 | 0.24 ± 0.14 | 0.21 ± 0.11 | 0.25 ± 0.08 | 0.20 ± 0.09 | 0.20 ± 0.1 |
| SNP CVCmax | 1.73 ± 2.01 | 1.88 ± 1.52 | 1.61 ± 1.21 | 2.38 ± 1.8 | 1.70 ± 1.3 | 1.40 ± 0.56 |
| SNP Tmax (sec) | 161.2 ± 88.5 | 131.3 ± 77.5 | 167.4 ± 66.3 | 138.8 ± 80.5 | 165.5 ± 56.5 | 166.9 ± 76.4 |
| ΔTcpO2 | 2.5 ± 4.0 | 9.2 ± 12.1 | 1.56 ± 4.8 | 1.56 ± 9.5 | 1.39 ± 3.4 | 0.89 ± 2.6 |
| ΔTcpO2max | 11.5 ± 3.9 | 18.4 ± 16.5 | 11.7 ± 3.6 | 13.6 ± 9.6 | 9.44 ± 7.7 | 8.0 ± 7.0 |
| V̇O2peak (ml kg− 1 min− 1) | 17.7 ± 4.7 | 21.9 ± 7.1* | 14.6 ± 2.9 | 18.5 ± 2.8* | 14.3 ± 6.9 | 14.7 ± 6.2 |
| Life satisfaction | 6.5 ± 1.6 | 8.1 ± 1.7*** | 8.4 ± 1.4* | 8.8 ± 1.1*** | 7.5 ± 1.6 | 4.9 ± 1.5 |
| Mobility | 2.4 ± 1.0 | 2.3 ± 0.8 | 1.9 ± 0.9 | 1.7 ± 1.0 | 1.9 ± 0.9 | 2.3 ± 1.2 |
| Self-care | 1.1 ± 0.3 | 1.1 ± 0.3 | 1.2 ± 0.4 | 1.0 ± 0.0 | 1.4 ± 0.9 | 1.7 ± 1.4 |
| Usual activity | 2.3 ± 1.3 | 1.9 ± 1.1 | 1.9 ± 1.0 | 1.6 ± 0.7 | 1.8 ± 1.0 | 2.4 ± 1.2 |
| Pain/ discomfort | 2.4 ± 1.0 | 2.3 ± 1.1 | 2.8 ± 1.1 | 1.8 ± 0.9 | 2.4 ± 0.7 | 2.8 ± 1.2 |
| Anxiety/ depression | 1.7 ± 0.8 | 1.5 ± 0.7 | 1.6 ± 0.7 | 1.2 ± 0.4 | 1.6 ± 0.7 | 1.9 ± 1.4 |
| Raynaud’s pain | 2.4 ± 1.4 | 1.8 ± 0.6* | 2.6 ± 1.5 | 1.9 ± 1.2* | 2.4 ± 0.9 | 3.1 ± 1.1 |
Endothelial function presented as cutaneous vascular conductance (CVC). Tmax is the time taken to reach peak perfusion. *p < 0.05 and ***p < 0.000 compared to the other groups
ACE arm crank ergometer, SNP sodium nitroprusside, ΔTcpO transcutaneous oxygen tension V̇O peak oxygen uptake
Endothelial-dependent correlations in arm cranking
| Soft lean mass (kg) | Fat-free mass (kg) | Skeletal muscle mass (kg) | V̇O2peak | V̇O2peak | ||
|---|---|---|---|---|---|---|
| ACh CVCmax | Pearson’s r | 0.529 | 0.520 | 0.530 | 0.120 | 0.220 |
| sig (2-tailed) | 0.116 | 0.123 | 0.115 | 0.740 | 0.569 | |
| n = 10 | 10 | 10 | 10 | 10 | 10 | |
Ach acetylcholine, CVC cutaneous vascular conductance